Skip to main content
. 2017 Apr 13;8(30):49093–49109. doi: 10.18632/oncotarget.17095

Figure 2. JMJD2A promotes liver cancer cell growth in vivo.

Figure 2

(A) The photography of xenograft tumors from Balb/C null mouse injected with Hep3B cells transfected with pCMV6-AC-GFP, pCMV6-AC-GFP-JMJD2A subcutaneously at armpit (B) The xenograft tumors weight(gram) in the two groups. Data were means of value from nine Balb/c mice, mean ± SEM, n = 8, *P < 0.05; **P < 0.01. Data were means of value from nine Balb/c mice, mean ± SEM, n = 8, *P < 0.05; **P < 0.01. (C) A portion of each xenograft tumor was fixed in 4% formaldehyde and embedded in paraffin, and the micrometers of sections (4 μm) were made for hematoxylin-eosin (HE) staining (original magnification×100).